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background: MicroRNAs (miRs) are emerging as promising biomarkers. The role of extracellular miRs as biomarkers in HIV infection and 
HIV-associated cardiovascular disease (CVD) has not been described.
Methods: We analyzed the expression of 192 plasma-derived miRs from 69 HIV-infected individuals and 24 uninfected controls using 
Taqman miR Assays and a high throughput RT-PCR instrument (Fluidigm). We also examined the association between 68 circulating miRs 
and flow-mediated dilatation of the brachial artery (FMD), a physiologic measure of endothelial function and a strong predictor of future 
CVD events, using Firefly Bioworks hydrogel particles-based miR assays. Comparisons were made using Student’s t-test, Wilcoxon rank-
sum test, ANOVA, and Kruskal-Wallis test where appropriate. False discovery rate was applied.
Results: HIV-infected individuals and controls were matched in age, gender, and traditional risk factors. The median age was 46 years 
(IQR 40 to 54) and 91% were men. Among the HIV patients, 72.5% were on antiretroviral therapy and 64% had an undetectable viral load. 
Twenty-nine miRs were differentially expressed in the plasma of HIV-infected individuals compared to controls (p<0.05 and FDR <0.15). 
In particular, miRs-29c, 146b, 223, and 382 have reported intracellular roles in HIV latency. MiRs-126, 145, and let-7 are differentially 
expressed in coronary artery disease (CAD) among individuals without HIV. Levels of miRs-34a, 27b, and 1183 varied with different FMD 
quartiles (p<0.05). Thirty-eight miRs were differentially expressed in the serum of HIV-infected individuals from the low FMD quartile 
compared with the top FMD quartile (p<0.05; thirty miRs had FDR<0.05 and eight miRs had FDR< 0.07). In this profile, in particular, miRs-
1, 133a, 133b, 208a, 208b, 499, 145, and 155 have been shown to be differentially expressed in CAD patients without HIV.
conclusion:  We demonstrate a unique miR expression profile of 29 miRs in HIV-infected individuals, and a unique profile of 38 miRs in 
HIV-infected individuals with high CVD risk and impaired endothelial function. Therefore, circulating miRs may be of diagnostic, prognostic, 
and potential therapeutic value in HIV-associated CVD.
